A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

Also called NCT02222480

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02222480
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02222480. Randomized; double masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2015-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
Condition
Hypertension
Intervention (Drug)
Fimasartan
Intervention (Drug)
Hydrochlorothiazide
Intervention (Drug)
Placebo
Lead sponsor
Boryung Pharmaceutical Co., Ltd (class: industry)
Collaborator
Seoul National University Hospital (class: other)

Record details

Record id
cardio:ct-nct02222480
Content hash
8b1c4cde45534784374dfe694ee9d1a48a16760c7e3d679130bd65b27e1937b7